Fig. 2From: Effect of TLR2 on the proliferation of inflammation-related colorectal cancer and sporadic colorectal cancerGeneral symptoms such as body weight, total days of diarrhea, and total days of bleeding. NC: WT without DMH-DSS; KC: TLR2−/− without DMH-DSS; NT: WT with DMH-DSS; KT: TLR2-/- with DMH-DSS. ***P < 0.001, KT vs NT group (n = 6)Back to article page